ECSP077262A - Composicion antihistaminica - Google Patents

Composicion antihistaminica

Info

Publication number
ECSP077262A
ECSP077262A EC2007007262A ECSP077262A ECSP077262A EC SP077262 A ECSP077262 A EC SP077262A EC 2007007262 A EC2007007262 A EC 2007007262A EC SP077262 A ECSP077262 A EC SP077262A EC SP077262 A ECSP077262 A EC SP077262A
Authority
EC
Ecuador
Prior art keywords
desloratadine
composition
polyol
composition consisting
antihistaminal
Prior art date
Application number
EC2007007262A
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Sankarnarayanan Anand
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ECSP077262A publication Critical patent/ECSP077262A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica estable que consiste de desloratadina ó una sal, solvato, derivado, polimorfo, hidrato ó enantiómero de la misma, y un portador que consiste de por lo menos un poliol. Las composiciones preferidas consisten de, además de la desloratadina, desde 50 hasta 80% de poliol, desde 5 hasta 15% de agente desintegrante, y desde 0,01 hasta 0,5% de un antioxidante y/ó un agente de quelación, todos por peso de la composición.También se provee para el uso de un poliol para estabilizar una composición farmacéutica que consiste de desloratadina.Un proceso para hacer una composición farmacéuticamente estable que consiste de desloratadina y uno ó más polioles, opcionalmente junto con otros excipientes farmacéuticamente aceptables, que consiste en combinar los ingredientes y formularlos para formar dicha composición.
EC2007007262A 2004-07-16 2007-02-16 Composicion antihistaminica ECSP077262A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN765MU2004 2004-07-16

Publications (1)

Publication Number Publication Date
ECSP077262A true ECSP077262A (es) 2007-03-29

Family

ID=35539416

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007262A ECSP077262A (es) 2004-07-16 2007-02-16 Composicion antihistaminica

Country Status (16)

Country Link
US (1) US20070281960A1 (es)
EP (1) EP1778195A2 (es)
JP (1) JP2008506679A (es)
KR (1) KR20070053221A (es)
AP (1) AP2007003915A0 (es)
AU (1) AU2005263958B2 (es)
BR (1) BRPI0513417A (es)
CA (1) CA2574188A1 (es)
EC (1) ECSP077262A (es)
IL (1) IL180724A0 (es)
MA (1) MA28801B1 (es)
MX (1) MX2007000632A (es)
NZ (1) NZ552998A (es)
TN (1) TNSN07013A1 (es)
WO (1) WO2006008512A2 (es)
ZA (1) ZA200701036B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
PT1698630E (pt) 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
GB0702837D0 (en) * 2007-02-14 2007-03-28 Boc Group Plc Method of treating a gas stream
EP2167084B1 (en) * 2007-06-12 2013-04-24 ALK-Abelló A/S An allergen dosage form comprising an antihistamine
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
EP2568970B1 (en) 2010-05-10 2018-12-05 Laboratorios Lesvi, S.L. Stable pharmaceutical formulations containing an antihistaminic
WO2012162439A2 (en) * 2011-05-23 2012-11-29 Cem-102 Pharmaceuticals, Inc. Compositions comprising fusidic acid and packages therefor
CN109498585B (zh) * 2018-12-21 2019-09-10 扬子江药业集团广州海瑞药业有限公司 一种枸地氯雷他定片剂及其制备方法
JP7515533B2 (ja) * 2022-04-28 2024-07-12 沢井製薬株式会社 デスロラタジン含有フィルムコーティング錠剤
CN118924679B (zh) * 2024-07-24 2025-05-16 湖南派格兰药业有限公司 一种氨甲环酸凝胶组合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
DE69714081T2 (de) * 1997-04-25 2002-11-14 Schering-Plough K.K., Osaka Augentropfen enthaltend ein loratidinmetabolit
US6506767B1 (en) * 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
PT1380297E (pt) * 1998-07-10 2009-07-06 Schering Corp Composições orais de 8-cloro-6,11-di-hidro-11-(4- piperidilideno)-5h-benzo[5,6]ciclo-hepta[1,2-b]piridina
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
DE60234884D1 (de) * 2002-09-24 2010-02-04 Gumlink As Kaugummi mit niedrigem Feuchtigkeitsgehalt
US20040258752A1 (en) * 2003-01-31 2004-12-23 Paruthi Manoj Kumar Taste masking pharmaceutical composition and process for its preparation
CN100563654C (zh) * 2003-07-22 2009-12-02 范敏华 一种地氯雷他定分散片及其制备方法
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
US7955620B2 (en) * 2003-12-23 2011-06-07 Sun Pharmaceutical Industries Limited Stable oral composition

Also Published As

Publication number Publication date
IL180724A0 (en) 2007-07-04
CA2574188A1 (en) 2006-01-26
ZA200701036B (en) 2008-05-28
AU2005263958B2 (en) 2011-04-14
KR20070053221A (ko) 2007-05-23
US20070281960A1 (en) 2007-12-06
NZ552998A (en) 2010-11-26
BRPI0513417A (pt) 2008-05-06
MA28801B1 (fr) 2007-08-01
AU2005263958A1 (en) 2006-01-26
WO2006008512A2 (en) 2006-01-26
AP2007003915A0 (en) 2007-02-28
WO2006008512A3 (en) 2006-08-03
MX2007000632A (es) 2007-03-30
TNSN07013A1 (en) 2008-06-02
JP2008506679A (ja) 2008-03-06
EP1778195A2 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
ECSP077262A (es) Composicion antihistaminica
AR056873A1 (es) Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas
AR055076A1 (es) Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica.
AR055070A1 (es) Una composicion farmaceutica de liberacion sostenida, proceso para la preparacion de dicha composicion, metodo para la utilizacion de la misma y su uso
ECSP066383A (es) Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias
CR10549A (es) Composicion farmaceutica que contienen un acido tetrahidrofolico
ECSP077185A (es) Derivados de piridina
AR063096A1 (es) Pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
ECSP088511A (es) Agonistas del receptor del neuropeptido-2
AR032136A1 (es) Compuestos espiroheterociclicos utiles como inhibidores reversibles de cisteina-proteasas
AR063097A1 (es) Pirazolopirimidinas[1,5-a] inhibidoras de quinasas dependientes de ciclina(cdk), composiciones farmaceuticas que las contienen y usos en el tratamiento de enfermedades proliferativas
SV2003000697A (es) Agonistas del receptor beta3-adrenergico y usos de los mismos ref. pc11008/700016/bb
PE20120476A1 (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
SV2004001418A (es) Formulaciones farmaceuticas de 5,7,14-triazaciclo 10.3.1.0.2,11.04,9) -hexadeca-2(11),3,5,7,9-pentaeno" ref.pc 23248
EA200870368A1 (ru) Антибиотические композиции с модифицированным высвобождением и способ их получения
GEP20094605B (en) Pyrazole derivatives, compositions containing such compounds and methods of use thereof
AR062397A1 (es) Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento de fibrosis
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
AR040434A1 (es) Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
AR020032A1 (es) Derivados de 1,3 -metil eritromicina.
WO2006081363A3 (en) Oral formulations for delivery of catecholic butanes including ndga compounds
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
AR064543A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
MXPA04012410A (es) Composiciones, formulaciones y equipo para el tratamiento de enfermedades pulmonares y respiratorias con deshidroepiandrosteronas, esteroides y agentes antimuscarinicos.